Summary
On intact human lymphocytes a specific binding site (BS) for125I-Cyanopindolol (125I-CYP), a derivative of the β-blocking drug pindolol, was characterized. Inhibition of binding for catecholamines in the following order of potency: l-isoprenaline > l-adrenaline > l-noradrenaline proves the BS as a β2-receptor subtype. In 77 healthy persons (36 females, 41 males) the number of BS amounted to 2,639±125 BS/cell without any significant correlation to age (17–86 years) or sex. The dissociation constant (KD) indicating the affinity of iodocyanopindolol to the BS on intact lymphocytes was K d =1.9±1.1×10−10 M. A change of the number of β-adrenergic receptors on intact human lymphocytes has been measured previously in asthmatics and in the myocardium of patients with congestive heart failure. We investigated a possible change in the β-receptors on lymphocytes by physical and mental activity (“stress”) in physicians going about their daily routine work. Persons left alone in a hospital room reading or sleeping were defined as “inactive controls”. The number of BS on intact lymphocytes was significantly higher in inactive persons at 8 a.m. (2,230±482 BS) compared to active persons (1,743±285 BS;P<0.05) and at 1 p.m. (2,394±253 BS vs 1,733±556;P<0.05) but not different at 6 p.m. (1,634±578 BS vs 1,768±588 BS;P<0.1). The K d remained unchanged under all conditions. The serum noradrenaline and adrenaline levels were also measured during the day. The serum adrenaline levels were higher in the active group than in the inactive group at 8 a.m. (46±11 pg/ml vs 22±8 pg/ml;P<0.01) and at 1 p.m. (36±13 pg/ml vs 13±5 pg/ml;P<0.01) but not at 6 p.m. (37±28 pg/ml vs 13±6 pg/ml;P<0.1). Our data clearly show higher serum adrenaline levels but fewer BS on intact human lymphocytes in active persons than in inactive persons at 8 a.m. and 1 p.m. The high catecholamine serum levels may cause a down-regulation of the number of β-receptors in the active persons.
Similar content being viewed by others
Abbreviations
- 125I-CYP:
-
125Iodocyanopindolol
- BS:
-
binding site
- K d :
-
dissociation constant
- cAMP:
-
cyclic adenosine monophosphate
References
Williams LT, Snyderman R, Lefkowitz RJ (1976) Identification ofβ-Adrenergic Receptors in Human Lymphocytes by (−).3H. Alprenolol Binding. J Clin Invest 57:149–155
Abrass IB, Scarpace PJ (1981) Human Lymphocyte Beta-adrenergic Receptors are Unaltered with Age. J Gerontol 36:298–301
Krawietz W, Werdan K, Schober M, Erdmann E, Rindfleisch GE, Hanning K (1982) Different numbers ofβ-receptors on human lymphocyte subpopulations. Biochem Pharmacol 31:133–136
Johnson GL, Wolfe BB, Harden TK, Molinoff PB, Perkins JP (1978) Role of beta-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells. J Biol Chem 253:1472–1480
Su Y, Harden TK, Perkins JP (1980) Catecholamine specific desensitization of adenylate cyclase: Evidence for a multistep process. J Biol Chem 255:7410–7419
Homburger V, Lucas M, Cantau B, Barabe J, Penit J, Bockaert J (1980) Further evidence that desensitization of beta-adrenergic sensitive adenylate cyclase proceeds in two steps: Modification of the coupling and loss of beta-adrenergic receptors. J Biol Chem 255:10436–10444
Parker CW, Smith JW (1973) Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma: Leukocyte responsiveness to beta-adrenergic agents. J Clin Invest 52:48–59
Gillespie E, Valentine MD, Lichtenstein L (1974) Cyclic AMP metabolism in asthma: Studies with leukocytes and lymphocytes. J Allergy Clin Immunol 53:27–33
Conolly ME, Greenacre JK (1976) The Lymphocyteβ-adrenoceptor in Normal subjects and patients with bronchial asthma: The effect of different forms of treatment on receptor function. J Clin Invest 58:1307–1316
Krall JF, Connelly M, Tuck ML (1980) Acute regulation of beta adrenergic catecholamine sensitivity in human lymphocytes. J Pharmacol Exp Ther 214:554–560
Lehmann M, Schmid P, Keul J (1983) Zum Verhalten und zur Wertigkeit von freien und konjugierten Plasma-Katecholaminen, von Adrenozeptorendichte und zentraler Hämodynamik bei Trainierten, Untrainierten und Patienten mit links-ventrikulärer Kontraktionsstörung. Herz/Kreisl 7:309–318
Bristow MR, Ginsburg R, Minobe W, Cubicciotti R, Sageman S, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity andβ-adrenergic-receptor density in failing human hearts. N Engl J Med 307:205–211
Thomas JA, Marks BH (1981) Plasma norepinephrine in congestive heart failure. Am J Cardiol 41:233–243
Francis GS, Goldsmith SR, Ziesche SM, Cohn JN (1982) Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol 49:1152–1156
Hjemdahl P (1979) Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: Comparison with a radioenzymatic method. Life Sci 25:131–138
Ackenheil M, Fröhler M, Goldig G, Rall G, Welter D (1982) Catecholamin-Bestimmung im Blut und Liquor mit Hochdruckflüssigkeitschromatographie und elektrochemischem Detektor. Arzneim Forsch 32:893
Scatchard G (1949) The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 51:660–672
Schocken DD, Roth GS (1977) Reducedβ-adrenergic receptor concentrations in ageing man. Nature 267:856–858
Krawietz W, Unterberg C, Werdan K, Erdmann E (1982) Zur alterabhängigen Änderung derβ-Rezeptoren an menschlichen Lymphozyten. Z Kardiol 71:195
Landmann R, Bittiger H, Bühler FR (1981) High affinity beta-2-adrenergic receptors in mononuclear leucocytes: Similar density in young and old normal subjects. Life Sci 29:1761–1771
Hui KKP, Gonolly ME (1981) Incresed numbers of beta receptors in orthostatic hypotension due to autonomic dysfunction. N Engl J Med 304:1473–1476
Brodde OE, Engel G, Hoyer D, Bock KD, Weber F (1981) Theβ-adrenergic receptor in human lymphocytes: Subclassification by the use of a new radio-ligand, (±)-125Iodocyanopindolol. Life Sci 29:2189–2198
Davies AO, Lefkowitz RJ (1984) Regulation ofβ-Adrenergic Receptors by Steroid Hormones. Ann Rev Physiol 46:119–130
Fraser J, Nadeau J, Robertson D, Wood AJJ (1981) Regulation of human leukocyte beta receptors by endogenous catecholamines: Regulationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol. J Clin Invest 67:1777–1784
Greenacre JK, Conolly ME (1978) Desensitization of theβ-adrenoceptor of lymphocytes from normal subjects and patients with phaeochromocytoma: Studies in vivo. Br J Clin Pharmacol 5:191–197
Tohmeh JF, Cryer PE (1980) Biphysic adrenergic modulation ofβ-adrenergic receptors in man: Agonist-induced early increment and late decrement inβ-adrenergic receptor number. J Clin Invest 65:836–840
Brodde OE, Daul A, O'Hara N (1984)β-Adrenoceptor changes in human lymphocytes, induced by dynamic exercise. Naunyn Schmiedebergs Arch Pharmacol 325:190–192
Lemmer B, Bathe K (1982) Stereospecific and circadian-phase-dependent kinetic behavior of d,l-, l-, and k-Propanolol in plasma, heart, and brain of light-dark-synchronized rats. J Cardiovasc Pharmacol 4:635–644
Lemmer B, Saller R (1973) Difference in the turnover of Noradrenaline in rat heart during day and night. Naunyn Schmiedebergs Arch Pharmacol 278:107–109
Lew GM (1975) Circadian rhythms in blood pressure and norepinephrine in genetically hypertensive and normotensive rats. Gen Pharmacol 7:35–40
Lemmer B, Saller R (1974) The effects of acute administration of Propanolol and Practolol on the uptake, content, release, and turnover of Noradrenaline in the rat heart in vivo. Naunyn Schmiedebergs Arch Pharmacol 282:85–96
Mann S, Altman DG, Raftery EB, Bannister R (1983) Circadian variation of blood pressure in autonomic failure. Circulation 68:477–483
Author information
Authors and Affiliations
Additional information
With support of Deutsche Forschungsgemeinschaft Kr 679/3-I
Rights and permissions
About this article
Cite this article
Krawietz, W., Klein, E.M., Unterberg, C. et al. Physical activity decreases the number of β-adrenergic receptors on human lymphocytes. Klin Wochenschr 63, 73–78 (1985). https://doi.org/10.1007/BF01733071
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01733071